Tamotsu Yoshiyama

Pfizer R&D Japan G.K
Shibuya, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Item Response Analyses of the Children's Depression Rating Scale-Revised Using Data from Clinical Studies.

Item Response Analyses of the Children's Depression Rating Scale-Revised Using Data from Clinical Studies.

Journal: Journal of child and adolescent psychopharmacology

Published: May 11, 2022

The efficacy of pregabalin for the treatment of neuropathic pain in Japanese subjects with moderate or severe baseline pain.

The efficacy of pregabalin for the treatment of neuropathic pain in Japanese subjects with moderate or severe baseline pain.

Journal: Journal of pain research

Published: April 10, 2019

Effectiveness of pregabalin for treatment of chronic cervical radiculopathy with upper limb radiating pain: an 8-week, multicenter prospective observational study in Japanese primary care settings.

Effectiveness of pregabalin for treatment of chronic cervical radiculopathy with upper limb radiating pain: an 8-week, multicenter prospective observational study in Japanese primary care settings.

Journal: Journal of pain research

Published: October 23, 2018

Pregabalin for Neuropathic Pain: Why Benefits Could Be Expected for Multiple Pain Conditions.

Pregabalin for Neuropathic Pain: Why Benefits Could Be Expected for Multiple Pain Conditions.

Journal: Clinical drug investigation

Published: July 23, 2016

Long-Term Extensions of Randomized Vaccination Trials of ACC-001 and QS-21 in Mild to Moderate Alzheimer's Disease.

Long-Term Extensions of Randomized Vaccination Trials of ACC-001 and QS-21 in Mild to Moderate Alzheimer's Disease.

Journal: Current Alzheimer research

Published: June 09, 2016

Effectiveness of pregabalin for the treatment of chronic low back pain with accompanying lower limb pain (neuropathic component): a non-interventional study in Japan.

Effectiveness of pregabalin for the treatment of chronic low back pain with accompanying lower limb pain (neuropathic component): a non-interventional study in Japan.

Journal: Journal of pain research

Published: September 09, 2015

Vanutide cridificar and the QS-21 adjuvant in Japanese subjects with mild to moderate Alzheimer's disease: results from two phase 2 studies.

Vanutide cridificar and the QS-21 adjuvant in Japanese subjects with mild to moderate Alzheimer's disease: results from two phase 2 studies.

Journal: Current Alzheimer research

Published: November 07, 2014

An open-label, long-term study examining the safety and tolerability of pregabalin in Japanese patients with central neuropathic pain.

An open-label, long-term study examining the safety and tolerability of pregabalin in Japanese patients with central neuropathic pain.

Journal: Journal of pain research

Published: August 13, 2014

Pregabalin treatment for peripheral neuropathic pain: a review of safety data from randomized controlled trials conducted in Japan and in the west.

Pregabalin treatment for peripheral neuropathic pain: a review of safety data from randomized controlled trials conducted in Japan and in the west.

Journal: Drug safety

Published: September 13, 2012

Efficacy and safety evaluation of pregabalin treatment over 52 weeks in patients with diabetic neuropathic pain extended after a double-blind placebo-controlled trial.

Efficacy and safety evaluation of pregabalin treatment over 52 weeks in patients with diabetic neuropathic pain extended after a double-blind placebo-controlled trial.

Journal: Journal of diabetes investigation

Published: November 30, 2011

Showing 1-10 of 10

Last Updated: 09/26/2026